Randomized, Controlled Study of the Safety and Immunogenicity of Peru‐15, a Live Attenuated Oral Vaccine Candidate for Cholera, in Adult Volunteers in Bangladesh

Journal of Infectious Diseases - United Kingdom
doi 10.1086/432074
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Oxford University Press (OUP)

Related search

Evaluation in Volunteers of a Candidate Live Oral Attenuated Salmonella Typhi Vector Vaccine.

Journal of Clinical Investigation
Medicine
1992English

Safety and Immunogenicity of a Live Attenuated Mumps Vaccine

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2014English

Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine in Flavivirus Naive Children

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2008English

Safety and Immunogenicity of a Live-Attenuated Junin (Argentine Hemorrhagic Fever) Vaccine in Rhesus Macaques

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
1993English

Safety and Immunogenicity of Different Immunization Regimens of CVD 103-HgR Live Oral Cholera Vaccine in Soldiers and Civilians in Thailand

Journal of Infectious Diseases
Infectious DiseasesAllergyImmunology
1992English

Extended Preclinical Safety, Efficacy and Stability Testing of a Live-Attenuated Chikungunya Vaccine Candidate

PLoS Neglected Tropical Diseases
PharmacologyPublic HealthEnvironmentalToxicologyInfectious DiseasesPharmaceuticsOccupational Health
2015English

Immunogenicity and Reactogenicity of Francisella Tularensis Strain 15/23-1 recA - The Candidate for a New Live Tularemia Vaccine

Epidemiology and Vaccine Prevention
2015English

A Phase II, Randomized, Safety and Immunogenicity Trial of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Children and Adults Living in Puerto Rico

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2015English

Comparative Randomized Study of Tolerability, Reactogenicity, Immunogenicity and Safety of the Vaccine «BiVac Polio» (Oral Poliovirus Vaccine Type 1,3)

Epidemiology and Vaccine Prevention
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy